194 related articles for article (PubMed ID: 36447287)
21. Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma.
He Y; Wang Y; Li P; Zhu S; Wang J; Zhang S
Dig Dis Sci; 2011 Mar; 56(3):681-8. PubMed ID: 20725785
[TBL] [Abstract][Full Text] [Related]
22. FGF5 methylation is a sensitivity marker of esophageal squamous cell carcinoma to definitive chemoradiotherapy.
Iwabu J; Yamashita S; Takeshima H; Kishino T; Takahashi T; Oda I; Koyanagi K; Igaki H; Tachimori Y; Daiko H; Nakazato H; Nishiyama K; Lee YC; Hanazaki K; Ushijima T
Sci Rep; 2019 Sep; 9(1):13347. PubMed ID: 31527639
[TBL] [Abstract][Full Text] [Related]
23. Network-based analysis identifies epigenetic biomarkers of esophageal squamous cell carcinoma progression.
Cheng CP; Kuo IY; Alakus H; Frazer KA; Harismendy O; Wang YC; Tseng VS
Bioinformatics; 2014 Nov; 30(21):3054-61. PubMed ID: 25015989
[TBL] [Abstract][Full Text] [Related]
24. Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients.
Kuo IY; Chang JM; Jiang SS; Chen CH; Chang IS; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
Int J Med Sci; 2014; 11(8):779-87. PubMed ID: 24936140
[TBL] [Abstract][Full Text] [Related]
25. p16, MGMT, RARbeta2, CLDN3, CRBP and MT1G gene methylation in esophageal squamous cell carcinoma and its precursor lesions.
Roth MJ; Abnet CC; Hu N; Wang QH; Wei WQ; Green L; D'Alelio M; Qiao YL; Dawsey SM; Taylor PR; Woodson K
Oncol Rep; 2006 Jun; 15(6):1591-7. PubMed ID: 16685400
[TBL] [Abstract][Full Text] [Related]
26. Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin β1/AKT pathway in esophageal squamous cell carcinoma: An E-cadherin-independent mechanism.
Zhang HF; Alshareef A; Wu C; Li S; Jiao JW; Cao HH; Lai R; Xu LY; Li EM
Oncotarget; 2015 Oct; 6(30):28949-60. PubMed ID: 26334393
[TBL] [Abstract][Full Text] [Related]
27. The prognostic role of FZD6 in esophageal squamous cell carcinoma patients.
Zhang J; Wang JL; Zhang CY; Ma YF; Zhao R; Wang YY
Clin Transl Oncol; 2020 Jul; 22(7):1172-1179. PubMed ID: 31748958
[TBL] [Abstract][Full Text] [Related]
28. Methylation silencing of TGF-β receptor type II is involved in malignant transformation of esophageal squamous cell carcinoma.
Ma Y; He S; Gao A; Zhang Y; Zhu Q; Wang P; Yang B; Yin H; Li Y; Song J; Yue P; Li M; Zhang D; Liu Y; Wang X; Guo M; Jiao Y
Clin Epigenetics; 2020 Feb; 12(1):25. PubMed ID: 32046777
[TBL] [Abstract][Full Text] [Related]
29. HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.
Yamashita K; Kim MS; Park HL; Tokumaru Y; Osada M; Inoue H; Mori M; Sidransky D
Mol Cancer Res; 2008 Jan; 6(1):31-41. PubMed ID: 18234960
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic inactivation of SPINT2 is associated with tumor suppressive function in esophageal squamous cell carcinoma.
Yue D; Fan Q; Chen X; Li F; Wang L; Huang L; Dong W; Chen X; Zhang Z; Liu J; Wang F; Wang M; Zhang B; Zhang Y
Exp Cell Res; 2014 Mar; 322(1):149-58. PubMed ID: 24269829
[TBL] [Abstract][Full Text] [Related]
31. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic inactivation of secreted frizzled-related protein 2 in esophageal squamous cell carcinoma.
Hao XW; Zhu ST; He YL; Li P; Wang YJ; Zhang ST
World J Gastroenterol; 2012 Feb; 18(6):532-40. PubMed ID: 22363119
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide hypomethylation and specific tumor-related gene hypermethylation are associated with esophageal squamous cell carcinoma outcome.
Hoshimoto S; Takeuchi H; Ono S; Sim MS; Huynh JL; Huang SK; Marzese DM; Kitagawa Y; Hoon DS
J Thorac Oncol; 2015 Mar; 10(3):509-17. PubMed ID: 25514805
[TBL] [Abstract][Full Text] [Related]
34. H3K9me3, H3K36me3, and H4K20me3 Expression Correlates with Patient Outcome in Esophageal Squamous Cell Carcinoma as Epigenetic Markers.
Zhou M; Li Y; Lin S; Chen Y; Qian Y; Zhao Z; Fan H
Dig Dis Sci; 2019 Aug; 64(8):2147-2157. PubMed ID: 30788686
[TBL] [Abstract][Full Text] [Related]
35. Hypermethylation of multiple tumor-related genes associated with DNMT3b up-regulation served as a biomarker for early diagnosis of esophageal squamous cell carcinoma.
Li B; Wang B; Niu LJ; Jiang L; Qiu CC
Epigenetics; 2011 Mar; 6(3):307-16. PubMed ID: 21150312
[TBL] [Abstract][Full Text] [Related]
36. HLA-DRB1 and HLA-DQB1 methylation changes promote the occurrence and progression of Kazakh ESCC.
Hu JM; Li L; Chen YZ; Liu C; Cui X; Yin L; Yang L; Zou H; Pang L; Zhao J; Qi Y; Cao Y; Jiang J; Liang W; Li F
Epigenetics; 2014 Oct; 9(10):1366-73. PubMed ID: 25437052
[TBL] [Abstract][Full Text] [Related]
37. DNA methyltransferase 3 beta regulates promoter methylation of microRNA-149 to augment esophageal squamous cell carcinoma development through the ring finger protein 2/Wnt/β-catenin axis.
Yang J; Zhang Q; Zhao P; Qiao T; Cao Z; Gao F; Liu M; Wu S
Bioengineered; 2022 Feb; 13(2):4010-4027. PubMed ID: 35129056
[TBL] [Abstract][Full Text] [Related]
38. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.
Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B
Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086
[TBL] [Abstract][Full Text] [Related]
39. A six-CpG panel with DNA methylation biomarkers predicting treatment response of chemoradiation in esophageal squamous cell carcinoma.
Chang WL; Lai WW; Kuo IY; Lin CY; Lu PJ; Sheu BS; Wang YC
J Gastroenterol; 2017 Jun; 52(6):705-714. PubMed ID: 27671002
[TBL] [Abstract][Full Text] [Related]
40. Multimodal analysis of cfDNA methylomes for early detecting esophageal squamous cell carcinoma and precancerous lesions.
Liu J; Dai L; Wang Q; Li C; Liu Z; Gong T; Xu H; Jia Z; Sun W; Wang X; Lu M; Shang T; Zhao N; Cai J; Li Z; Chen H; Su J; Liu Z
Nat Commun; 2024 May; 15(1):3700. PubMed ID: 38697989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
